Immune Response Completed Phase Trials for Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (propiolactone inactivated) (DB11046)

IndicationStatusPhase
DBCOND0034832 (Immune Response)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02872311Open-Label Influenza Vaccine EvaluationBasic Science
NCT00902278Immune Responses Induced by Different Licensed Influenza VaccinesBasic Science